Chemoinformaics analysis of (Z)-PHENYLACETALDOXIME
| Molecular Weight | 135.166 | nRot | 2 |
| Heavy Atom Molecular Weight | 126.094 | nRig | 7 |
| Exact Molecular Weight | 135.068 | nRing | 1 |
| Solubility: LogS | -1.966 | nHRing | 0 |
| Solubility: LogP | 1.659 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.2631 |
| nHD | 1 | BPOL | 9.02886 |
| QED | 0.373 |
| Synth | 2.229 |
| Natural Product Likeliness | 0.481 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.011 |
| HIA | 0.039 |
| CACO-2 | -4.573 |
| MDCK | 0.0000297 |
| BBB | 0.936 |
| PPB | 0.58532 |
| VDSS | 1.729 |
| FU | 0.406751 |
| CYP1A2-inh | 0.873 |
| CYP1A2-sub | 0.112 |
| CYP2c19-inh | 0.614 |
| CYP2c19-sub | 0.097 |
| CYP2c9-inh | 0.096 |
| CYP2c9-sub | 0.204 |
| CYP2d6-inh | 0.44 |
| CYP2d6-sub | 0.504 |
| CYP3a4-inh | 0.084 |
| CYP3a4-sub | 0.22 |
| CL | 5.502 |
| T12 | 0.753 |
| hERG | 0.023 |
| Ames | 0.815 |
| ROA | 0.08 |
| SkinSen | 0.641 |
| Carcinogencity | 0.816 |
| EI | 0.986 |
| Respiratory | 0.161 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.894946 |